(Q48090381)

8 February 2018

title

A comparative study of high-dose and low-dose ACTH therapy for West syndrome (English)

1 reference

8 February 2018

author name string

Yanagaki S

1

1 reference

8 February 2018

Oguni H

2

1 reference

8 February 2018

Hayashi K

3

1 reference

8 February 2018

Imai K

4

1 reference

8 February 2018

Funatuka M

5

1 reference

8 February 2018

Tanaka T

6

1 reference

8 February 2018

Yanagaki M

7

1 reference

8 February 2018

Osawa M

8

1 reference

8 February 2018

publication date

1 October 1999

1 reference

8 February 2018

published in

Brain and Development

1 reference

8 February 2018

volume

21

1 reference

8 February 2018

issue

7

1 reference

8 February 2018

page(s)

461-467

1 reference

8 February 2018

The effect of ACTH therapy upon infantile spasms

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Long-term prognosis after infantile spasms: a statistical study of prognostic factors in 200 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

A Long-term Follow-up Study of 214 Children with the Syndrome of Infantile Spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Double-blind study of ACTH vs prednisone therapy in infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

A Prospective Study of Infantile Spasms: Clinical and Therapeutic Correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Therapeutic efficacy of ACTH in symptomatic infantile spasms with hypsarrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

ACTH therapy in infantile spasms: side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Cushing's ulcer as a consequence of adrenocorticotropic hormone administration for infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Hypertrophic cardiomyopathy during corticotropin therapy for infantile spasms. A clinical and echocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Cranial Computed Tomography (CCT) Findings in Children Treated with ACTH and Dexamethasone: First Results

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Apparent brain atrophy and subdural hematoma following ACTH therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

ACTH therapy in infantile spasms: relationship between dose of ACTH and initial effect or long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

The treatment of infantile spasms by child neurologists

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Medical treatment of West syndrome in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Reversible cerebral atrophy caused by corticotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Cerebral Atrophy Following ACTH Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Cortisone-Induced Growth Failure in Neonatal Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

DNA, ganglioside and sulfatide in brains of rats given corticosterone in infancy, with an estimate of cell loss during development

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Suppression of 2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in suckling rat brain by ACTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

Combination therapy of infantile spasms with high-dose pyridoxal phosphate and low-dose corticotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

West syndrome: individualized ACTH therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2899%2900053-4

7 January 2021

10.1016/S0387-7604(99)00053-4

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018